Interrupting highly active antiretroviral therapy in patients with HIV
- 10 January 2005
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 3 (1) , 51-60
Abstract
Scheduled treatment interruptions are preplanned interruptions of antiretroviral treatment, which may be directed by time (e.g., cycles of 8 weeks on treatment and 8 weeks off treatment); the concentration of CD4+ lymphocytes (the CD4 count); HIV-1 RNA concentration (viral load); or other factors. This review covers the rationale of scheduled treatment interruptions and the different strategies that have been explored. It examines the issue of autovaccination, resistance and other risks and benefits. Scheduled-treatment-interruption studies in three populations are discussed: patients who initiated highly active antiretroviral therapy during acute HIV infection; patients with successfully treated chronic HIV infection; and patients with highly active antiretroviral therapy failure.Keywords
This publication has 58 references indexed in Scilit:
- Theme 5 Genotypic resistance tests for the management of structured therapeutic interruptions after multiple drug failureScandinavian Journal of Infectious Diseases, 2003
- Aseptic meningitis and acute HIV syndrome after interruption of antiretroviral therapyAIDS, 2003
- Structured Treatment Interruption in Patients with Multidrug-Resistant Human Immunodeficiency VirusNew England Journal of Medicine, 2003
- Management of Severely Immunocompromised Human Immunodeficiency Virus Type 1—Infected African Orphans with Structured Treatment Interruption: Another Kind of Salvage TherapyClinical Infectious Diseases, 2003
- HIV lipodystrophyAIDS, 2003
- Enhanced risk of HIV sexual transmission during structured treatment interruptionSexually Transmitted Infections, 2003
- A cytostatic drug improves control of HIV-1 replication during structured treatment interruptionsAIDS, 2003
- Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countriesExpert Opinion on Investigational Drugs, 2002
- Structured Treatment Interruption in Patients Infected with HIVDrugs, 2002
- The Cost Effectiveness of Combination Antiretroviral Therapy for HIV DiseaseNew England Journal of Medicine, 2001